The Diarylheptanoid Hirsutenone Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin via Modulation of Apoptosis-inducing Factor and X-linked Inhibitor of Apoptosis

Cisplatin (CDDP) and its derivatives are considered first-line treatments for ovarian cancer (OVCA). However, despite initial results that often appear promising, in most cases patients will return with recurrent disease that fails to respond to further chemotherapy. We assayed a number of food phyt...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Im-aram, Akechai, Lee, Jihoon, Suh, Jeong-Yong, Lee, Ki-Won, Lee, Hyong Joo, Tsang, Benjamin K.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Biochemistry and Molecular Biology 2014
Assuntos:
Molecular Bases of Disease
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3894349/
https://ncbi.nlm.nih.gov/pubmed/24247248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M113.513879
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares